March 3, 2026

Pulse Biosciences, Inc (PLSE) Stock Analysis: Is a 59% Upside Within Reach?

Pulse Biosciences, Inc (NASDAQ: PLSE), a burgeoning player in the healthcare sector, is making waves in the medical instruments and supplies industry with its innovative bioelectric..

Progyny, Inc. (PGNY) Stock Analysis: Potential 68% Upside with Strong Buy Ratings in Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY), a healthcare plans company specializing in fertility and family-building benefits, is drawing attention with a notable potential upside of 68.39%, according to..

Vera Therapeutics, Inc. (VERA) Stock Analysis: 94.88% Potential Upside Signals Compelling Opportunity

Vera Therapeutics, Inc. (NASDAQ: VERA), a biotechnology company strategically positioned in the healthcare sector, is catching the eye of investors with a striking potential upside of..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A Biotech Gem with 51% Upside Potential

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is gaining traction among investors as a promising player in the biotechnology sector. With a current market cap of $2.9 billion,..

ANI Pharmaceuticals (ANIP) Stock Analysis: A Compelling 47% Upside Potential Awaits Investors

For investors seeking opportunities in the healthcare sector, ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling case. With a potential upside of 47.07%, as indicated by..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Unveiling a 29% Upside Potential for Savvy Investors

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering entity in the biotechnology sector, is garnering attention with its robust 29.39% potential upside, according to recent analyst ratings...

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 44.65% Potential Upside in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX), a prominent player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 44.65% based on current..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 37.76% Potential Upside

Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices industry, is capturing investor attention with a compelling potential upside of 37.76%. Known for its..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Navigating a 38.97% Potential Upside Amid Biotech Challenges

Investors eyeing the healthcare sector may find ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) an intriguing prospect. With a market capitalization of $3.86 billion, ACADIA stands as a..

Twist Bioscience Corporation (TWST) Stock Analysis: A Look at the 8.71% Potential Upside in the Healthcare Sector

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector, specifically within the diagnostics and research industry, as it continues to capture the interest..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Strong Buy Ratings and a Promising 14.42% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biotechnology firm specializing in peptide-based therapeutics, is capturing investor attention with its dynamic pipeline and robust analyst support. With a..

Premier, Inc. (PINC) Stock Analysis: Navigating a Stable Yet Cautious Path in Healthcare

Premier, Inc. (NASDAQ: PINC) stands as a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.34..

QuidelOrtho Corporation (QDEL) Stock Analysis: Potential Upside of Over 50% Amidst Strategic Positioning in Healthcare

QuidelOrtho Corporation (NASDAQ: QDEL) is a compelling entity within the healthcare sector, focusing on medical devices. With a market capitalization of $1.54 billion, the company specializes..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Anticipating a 40% Upside with Strong Buy Ratings

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a promising player in the biotechnology sector, is garnering attention from investors with its significant 40.35% potential upside, as indicated by..

SS Innovations International (SSII) Stock Analysis: Unpacking the 192.5% Revenue Growth in the Healthcare Sector

In the dynamic landscape of the healthcare sector, India-based SS Innovations International Inc. (SSII) is making waves with its impressive revenue growth. The company, operating in..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 60% Upside Potential Amidst Healthcare Growth

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector, presents a compelling opportunity for investors seeking exposure to the medical care facilities industry...

ARS Pharmaceuticals, Inc. (SPRY): Analyst Consensus Sees 214% Upside Potential

Investors eyeing opportunities in the biotechnology sector may want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a promising player focusing on innovative..

Schrodinger, Inc. (SDGR) Stock Analysis: Investors Eye a Potential 93% Upside Amid Market Turbulence

Schrodinger, Inc. (NASDAQ: SDGR) is capturing investor attention with a compelling potential upside of 93.42%, according to recent analyst ratings. As a prominent player in the..

Artivion, Inc. (AORT) Stock Analysis: Exploring a 33% Upside Potential in the Medical Device Sector

Artivion, Inc. (AORT), a prominent player in the healthcare sector specializing in medical devices, has been attracting investor attention with its diverse product range and promising..

Concentra Group Holdings Parent (CON) Stock Analysis: 20% Upside Potential with Strong Buy Ratings

For investors eyeing opportunities in the healthcare sector, Concentra Group Holdings Parent, Inc. (CON) presents an intriguing proposition. With a market capitalization of $3.04 billion, the..

Search

Funds

March 3, 2026

Search

Funds

March 3, 2026

FTSE 100

Funds